AU2000255261A1 - Means for maintenance and/or correction of glucose concentration in blood - Google Patents

Means for maintenance and/or correction of glucose concentration in blood

Info

Publication number
AU2000255261A1
AU2000255261A1 AU2000255261A AU5526100A AU2000255261A1 AU 2000255261 A1 AU2000255261 A1 AU 2000255261A1 AU 2000255261 A AU2000255261 A AU 2000255261A AU 5526100 A AU5526100 A AU 5526100A AU 2000255261 A1 AU2000255261 A1 AU 2000255261A1
Authority
AU
Australia
Prior art keywords
blood
correction
maintenance
glucose concentration
polymeric matrix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2000255261A
Other languages
English (en)
Inventor
Iouri Gennadievich Bobkov
Anatoliy Borisovich Davydov
Iouri Tikhonovich Kalinin
Gennadiy Ljvovich Khromov
Boris Ivanovich Leonov
Tatjana Igorevna Solodkaya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ctp Cable Technology Procurement AG
Original Assignee
C T P CABLE TECHNOLOGY PROCURE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by C T P CABLE TECHNOLOGY PROCURE filed Critical C T P CABLE TECHNOLOGY PROCURE
Publication of AU2000255261A1 publication Critical patent/AU2000255261A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
AU2000255261A 2000-05-26 2000-05-26 Means for maintenance and/or correction of glucose concentration in blood Abandoned AU2000255261A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2000/004826 WO2001091784A1 (en) 2000-05-26 2000-05-26 Means for maintenance and/or correction of glucose concentration in blood

Publications (1)

Publication Number Publication Date
AU2000255261A1 true AU2000255261A1 (en) 2001-12-11

Family

ID=8163961

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2000255261A Abandoned AU2000255261A1 (en) 2000-05-26 2000-05-26 Means for maintenance and/or correction of glucose concentration in blood

Country Status (6)

Country Link
US (1) US7259139B1 (de)
EP (1) EP1289542B1 (de)
AT (1) ATE401095T1 (de)
AU (1) AU2000255261A1 (de)
DE (1) DE60039540D1 (de)
WO (1) WO2001091784A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007047922A2 (en) * 2005-10-19 2007-04-26 Smartcells, Inc. Polymer-drug conjugates

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2504408B1 (fr) * 1981-04-24 1986-02-14 Couvreur Patrick Procede de preparation de particules submicroscopiques, particules ainsi obtenues et compositions pharmaceutiques les contenant
SU1011126A1 (ru) * 1981-07-14 1983-04-15 Всесоюзный научно-исследовательский и испытательный институт медицинской техники Средство дл лечени сахарного диабета
US4666704A (en) * 1985-05-24 1987-05-19 International Minerals & Chemical Corp. Controlled release delivery system for macromolecules
IE61651B1 (en) * 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
US6277410B1 (en) * 1992-10-08 2001-08-21 Supratek Pharma Inc. Copolymer compositions for oral delivery
EP0842209B1 (de) * 1995-07-28 2006-10-11 Genzyme Corporation Biologische abbaubare multiblokhydrogene und ihre verwendung wie trägerstoffe fur kontrollierte freisetzung pharmakologisch activen werstoffe und gewebekontaktmaterialen
SE505146C2 (sv) * 1995-10-19 1997-06-30 Biogram Ab Partiklar för fördröjd frisättning

Also Published As

Publication number Publication date
WO2001091784A1 (en) 2001-12-06
EP1289542A1 (de) 2003-03-12
ATE401095T1 (de) 2008-08-15
EP1289542B1 (de) 2008-07-16
DE60039540D1 (de) 2008-08-28
US7259139B1 (en) 2007-08-21

Similar Documents

Publication Publication Date Title
AU2845599A (en) Pharmaceutical compositions and their use
AU3203800A (en) A method for the preparation of uhmwpe doped with an antioxidant and an implant made thereof
WO2006052285A3 (en) Polymeric nanoparticles and nanogels for extraction and release of compounds
GEP20063917B (en) Pulmonary administration of chemically modified insulin
EP1196444B8 (de) Exendin-4 konjugate und ihre medizinische verwendung
CA2346438A1 (en) Utilisation of dialkylfumarates for treating host-versus-graft reactions and auto-immune diseases
GB9902652D0 (en) Process
NO962088D0 (no) Preparat for in vivo-produksjon av terapeutiske produkter
DK0973819T3 (da) Ikke-antigene forgrenede polymerkonjugater
PT1028753E (pt) Libertacao de moleculas de poli(etilenoglicol)-conjugado a partir de hidrogeles degradaveis
AU3310595A (en) Compositions and methods for identifying biologically active molecules
AU6559800A (en) Use of hyaluronic acid derivatives in pharmaceutical preparations and biomaterials for the prevention and treatment of cutaneous scars
AU2001247968A1 (en) Use of asiatic acid or asiaticoside for treatment of cancer
BRPI0414979A (pt) preparação sólida
HK1047707A1 (zh) (+)-曲马朵、o-去甲曲马朵或(+)-o-去甲曲马朵、o-去甲-n-单-去甲-曲马朵或(+)-o-去甲-n-单-去甲-曲马朵治疗尿失禁的用途
WO1997031934A3 (de) Neue metabolisierbare lipopolyamine, deren darstellung und anwendung
DE60018564D1 (de) Funktionsfähige poly-alpha-aminosäurederivate zur modifizierung von biologisch wirksamen stoffen und deren herstellung
AU4104397A (en) Implant consisting of a carrier material containing medical substances and method to produce such an implant
BR0009771A (pt) Utilização de derivados de bisindóis indigóides capazes de penetrarem na membrana de células
AU4765999A (en) Polyionic hydrogels based on xanthan and chitosan for stabilising and controlledrelease of vitamins
AU2668400A (en) Human antibiotic proteins
MX9805939A (es) Formas solidas de administracion, de liberacion instantanea y procesos para su produccion.
UY27373A1 (es) Formulaciones de interferón beta-humano
DE60004204D1 (de) Pharmazeutische zusammensetzungen, bestimmt zur oralen verabreichung von phloroglucinol sowie deren herstellung
PL361732A1 (en) Use of a biological material containing three-dimensional scaffolds of hyaluronic acid derivatives for the preparation of implants in arthroscopy and kit for instruments for implanting said biological material by arthroscopy